NCT02081469View on ClinicalTrials.gov

Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 17, 2014

Primary Completion Date

August 5, 2019

Study Completion Date

August 5, 2019

Conditions
Hepatitis B, ChronicTumor
Interventions
OTHER

TDF

To compare extend TDF 24 wks versus 48 wks prophylaxis efficacy in chemotherapy CHB patients

Trial Locations (1)

105

Chang Gung Memorial Hospital, Taipei

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

Chang Gung Memorial Hospital

OTHER